SAN FRANCISCO -- Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free survival (PFS) in patients with unresectable hepatocellular ...

In this review we will discuss TACE, TAE and TOCE in detail. The TACE procedure consists of the injection of anticancer drugs mixed with or without lipiodol into the hepatic artery followed by the ...

Combining transarterial chemoembolization (TACE) with lenvatinib (Lenvima) as first-line treatment for advanced hepatocellular carcinoma (HCC) prolonged survival compared with lenvatinib alone, the ...

Please provide your email address to receive an email when new articles are posted on . Treatment with transarterial chemoembolization and Nexavar improved progression-free survival compared with ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival ...

Transarterial chemoembolization (TACE) can prevent tumor progression in patients with hepatocellular carcinoma (HCC) awaiting orthotropic liver transplantation (OLT); but the long-term outcome of ...

Staging of advanced hepatocellular carcinoma patients in the targeted therapy era. Background: We examine treatment patterns and associated survival outcomes of TACE at all stages of Hepatocellular ...

Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial. Background: TACE is regarded as the standard of care ...

TACE/ADAM17 is a transmembranous protease that cleaves membrane-bound growth factors like EGFR ligands. TACE-dependent proteolysis is regulated by its inhibitor, tissue inhibitor of metalloproteinases ...

Lenvima plus Keytruda with TACE significantly improved progression-free survival in unresectable, non-metastatic hepatocellular carcinoma compared to TACE with placebo. The study reported a median ...

Embolization is an effective approach for the management of HCC with noncurative options. However, it has several limitations, with reduced efficacy for large tumors. Multimodal treatments are being ...